Search results for "Myocardial infarction"
Adverse cardiac events rare in chest pain patients treated and discharged by ED
Among patients who presented to the ED with chest pain but were not diagnosed with myocardial infarction, risk of acute myocardial infarction, death, or coronary revascularization within 30 days did not appear to be affected by whether they were admitted, a retrospective study found.
https://acphospitalist.acponline.org/weekly/archives/2021/05/26/3.htm
26 May 2021
High-sensitivity troponin-based pathway safe, effective for chest pain patients without CAD
The American College of Cardiology expert consensus decision pathway for chest pain did not meet the criteria for safety among patients with known coronary artery disease (CAD), according to a study conducted in U.S. EDs.
https://acphospitalist.acponline.org/archives/2024/03/27/high-sensitivity-troponin-based-pathway-safe-effective-for-chest-pain-patients-without-cad.htm
27 Mar 2024
Risk for adverse outcomes after early-onset MI appears higher in Black patients
Researchers calculated that 45.7% of race-related disparity in major adverse cardiac events after myocardial infarction (MI) among younger and middle-aged patients was due to lower income, highlighting the importance of social determinants of health.
https://acphospitalist.acponline.org/weekly/archives/2021/09/01/3.htm
1 Sep 2021
New score developed to improve risk stratification in type 2 myocardial infarction
The T2-risk score incorporates age, ischemic heart disease, heart failure, diabetes, myocardial ischemia on electrocardiogram, heart rate, anemia, estimated glomerular filtration rate, and maximal cardiac troponin concentration.
https://acphospitalist.acponline.org/archives/2023/01/18/new-score-developed-to-improve-risk-stratification-in-type-2-myocardial-infarction.htm
18 Jan 2023
3-hour troponin level may help rule out NSTEMI in ED patients triaged to observation
A previously proposed cutoff for 3-hour change in high-sensitivity cardiac troponin T of 7 ng/L missed 66.7% of ED patients with non-ST-segment elevation myocardial infarction (NSTEMI), but a cutoff of 15 ng/L combined with a 0/3-hour absolute change of less than 4 ng/L missed less than 1%.
https://acphospitalist.acponline.org/weekly/archives/2021/08/18/3.htm
18 Aug 2021
Strained finances linked to increased mortality following myocardial infarction
Patients under severe financial strain had higher risk of death in the six months after hospital discharge after acute myocardial infarction, even after accounting for medical complexity, functional impairments, and conditions of aging such as impaired mobility.
https://acphospitalist.acponline.org/archives/2022/02/23/strained-finances-linked-to-increased-mortality-following-myocardial-infarction.htm
23 Feb 2022
American Heart Association issues scientific statement on cardiogenic shock in older adults
The statement provides suggestions for clinical practice, highlighting the crucial role of individualized risk assessment, an interdisciplinary approach, and patient-centered decision making in the management of cardiogenic shock among older adults.
https://acphospitalist.acponline.org/archives/2024/03/06/american-heart-association-issues-scientific-statement-on-cardiogenic-shock-in-older-adults.htm
6 Mar 2024
Care disparities, barriers common in homeless patients hospitalized for acute MI
Coronary angiography, percutaneous coronary intervention (PCI), and coronary artery bypass grafting were done less frequently in homeless patients, and homeless patients who did undergo PCI were more likely to receive bare-metal stents, according to a recent study.
https://acphospitalist.acponline.org/weekly/archives/2020/03/25/4.htm
25 Mar 2020
February 2007
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2007/02/
Studies look at gap between practice and optimal pharmacotherapy after MI
Patients who have had a myocardial infarction (MI) may benefit from lower doses of beta-blockers than those used in clinical trials, and mineralocorticoid receptor antagonists are often not prescribed as recommended.
https://acphospitalist.acponline.org/weekly/archives/2021/07/14/2.htm
14 Jul 2021